NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy
Related Experiment Video
Updated: Sep 26, 2026

Visualization of Vascular Ca2+ Signaling Triggered by Paracrine Derived ROS
Published on: December 21, 2011
Jianhua Liu1, Fang Yang, Xiao-Ping Yang
1Hypertension and Vascular Research Division and the Biostatistics Department, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, Mich 48202-2689, USA.
Objective:
Our preliminary data suggested that angiotensin II (Ang II)-induced reactive oxygen species are involved in intercellular adhesion molecule-1 (ICAM-1) expression and leukocyte infiltration in the rat thoracic aorta. Other reports demonstrating reactive oxygen species-induced cell growth suggested a potential role of NAD(P)H oxidase in vascular hypertrophy. In the present study, we postulate that NAD(P)H oxidase is functionally involved in Ang II-induced ICAM-1 expression, macrophage infiltration, and vascular growth, and that oxidase inhibition attenuates these processes independently of a reduction in blood pressure.
Methods And Results:
Rats were infused subcutaneously with vehicle or Ang II (750 microg/kg per day) for 1 week in the presence or absence of gp91 docking sequence (gp91ds)-tat peptide (1 mg/kg per day), a cell-permeant inhibitor of NAD(P)H oxidase. Immunohistochemical staining for ICAM-1 and ED1, a marker of monocytes and macrophages, showed that both were markedly increased with Ang II compared with vehicle and were reduced in rats receiving Ang II plus gp91ds-tat. This effect was accompanied by an Ang II-induced increase in medial hypertrophy that was attenuated by coinfusion of gp91ds-tat; however, gp91ds-tat had no effect on blood pressure.
Conclusions:
Ang II-enhanced NAD(P)H oxidase plays a role in the induction of ICAM-1 expression, leukocyte infiltration, and vascular hypertrophy, acting independently of changes in blood pressure.
Insights
Angiotensin II (Ang II) increases vascular inflammation and growth by activating NAD(P)H oxidase. Inhibiting this enzyme reduces intercellular adhesion molecule-1 (ICAM-1) expression and leukocyte infiltration without affecting blood pressure.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Vascular Biology
Background:
- Reactive oxygen species (ROS) are implicated in Angiotensin II (Ang II)-induced intercellular adhesion molecule-1 (ICAM-1) expression and leukocyte infiltration.
- NAD(P)H oxidase is a key source of ROS and has been linked to cell growth and vascular hypertrophy.
Purpose of the Study:
- To investigate the role of NAD(P)H oxidase in Ang II-induced ICAM-1 expression, macrophage infiltration, and vascular growth.
- To determine if NAD(P)H oxidase inhibition attenuates these processes independently of blood pressure changes.
Main Methods:
- Rats were infused with Ang II or vehicle, with or without a cell-permeant NAD(P)H oxidase inhibitor (gp91ds-tat peptide).
- Immunohistochemical staining was used to assess ICAM-1 and ED1 (macrophage marker) expression.
- Medial hypertrophy and blood pressure were measured.
Main Results:
- Ang II significantly increased ICAM-1 expression, macrophage infiltration, and medial hypertrophy compared to vehicle.
- Coinfusion with gp91ds-tat peptide attenuated these Ang II-induced effects.
- The NAD(P)H oxidase inhibitor did not affect blood pressure.
Conclusions:
- NAD(P)H oxidase activation by Ang II contributes to ICAM-1 expression, leukocyte infiltration, and vascular hypertrophy.
- Inhibition of NAD(P)H oxidase offers a potential therapeutic strategy for vascular remodeling independent of blood pressure modulation.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Heart Failure II: Pathophysiology
Cellular Adaptation II: Hypertrophy
Nitric Oxide Signaling Pathway
